The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants

TL;DR

This study investigates how the surface charge of nanoparticles influences their interaction with pulmonary surfactants, revealing charge-dependent aggregation and potential impacts on lung function.

Contribution

It provides new insights into the biophysical interactions between charged nanoparticles and pulmonary surfactants, highlighting the role of surface charge in aggregation behavior.

Findings

Nanoparticles induce charge-dependent vesicle aggregation.

Surface charge determines the extent of nanoparticle-surfactant interaction.

Supported lipid bilayer formation was not observed in studied conditions.

Abstract

Inhaled nanoparticles traveling through the airways are able to reach the respiratory zone of the lungs. In such event, the incoming particles first enter in contact with the liquid lining the alveolar epithelium, the pulmonary surfactant. The pulmonary surfactant is composed of lipids and proteins that are assembled into large vesicular structures. The question of the nature of the biophysicochemical interaction with the pulmonary surfactant is central to understand how the nanoparticles can cross the air-blood barrier. Here we explore the phase behavior of sub-100 nm particles and surfactant substitutes in controlled conditions. Three types of surfactant mimetics, including the exogenous substitute Curosurf, a drug administred to infants with respiratory distress syndrome are tested together with aluminum oxide (Al2O3), silicon dioxide (SiO2) and polymer (latex) nanoparticles. The main result here is the observation of the spontaneous nanoparticle-vesicle aggregation induced by Coulombic attraction. The role of the surface charges is clearly established. We also evaluate the supported lipid bilayer formation recently predicted and find that in the cases studied these structures do not occur. Pertaining to the aggregate internal structure, fluorescence microscopy ascertains that the vesicles and particles are intermixed at the nano- to microscale. With particles acting as stickers between vesicles, it is anticipated that the presence of inhaled nanomaterials in the alveolar spaces could significantly modify the interfacial and bulk properties of the pulmonary surfactant and interfere with the lung physiology.